Abstract
Refractory hypoxia in adult respiratory distress syndrome remains a highly lethal process. Low tidal volume ventilation maneuvers have improved outcomes. In severe Acute Respiratory Distress Syndrome (ARDS), the mortality remains high. Veno-Venous Extracorporeal Membranous Oxygenation (VV ECMO) has been employed to treat this very sick group of patients. The proper selection of patients for VV ECMO as well as proper critical care management while on ECMO remains the key to improved outcomes. This review article details the current state of the art therapy for VV ECMO for refractory hypoxia, and describes controversies and future directions.
Keywords: ARDS, avalon, cardiohelp, ECMO, PEEP, refractory hypoxia.
Current Respiratory Medicine Reviews
Title:ECMO for Refractory Hypoxia; Current State of the Art and Future Directions
Volume: 10 Issue: 1
Author(s): John E. Fetter, Iqbal Ratnani and Faisal Masud
Affiliation:
Keywords: ARDS, avalon, cardiohelp, ECMO, PEEP, refractory hypoxia.
Abstract: Refractory hypoxia in adult respiratory distress syndrome remains a highly lethal process. Low tidal volume ventilation maneuvers have improved outcomes. In severe Acute Respiratory Distress Syndrome (ARDS), the mortality remains high. Veno-Venous Extracorporeal Membranous Oxygenation (VV ECMO) has been employed to treat this very sick group of patients. The proper selection of patients for VV ECMO as well as proper critical care management while on ECMO remains the key to improved outcomes. This review article details the current state of the art therapy for VV ECMO for refractory hypoxia, and describes controversies and future directions.
Export Options
About this article
Cite this article as:
Fetter E. John, Ratnani Iqbal and Masud Faisal, ECMO for Refractory Hypoxia; Current State of the Art and Future Directions, Current Respiratory Medicine Reviews 2014; 10 (1) . https://dx.doi.org/10.2174/1573398X10666140407212724
DOI https://dx.doi.org/10.2174/1573398X10666140407212724 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
Call for Papers in Thematic Issues
Exposure to PM2.5 components is associated with respiratory diseases
Through continuous research on the relationship between risk factors and health, it has been found that air pollution, especially atmospheric particulate matter pollution, has become one of the main sources of global disease burden. From 1990 to 2022, the concentration of atmospheric particulate matter pollution has increased by more than ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Killing of Human Neuroblastoma Cells by the Small Molecule JQ1 Occurs in a p53-Dependent Manner
Anti-Cancer Agents in Medicinal Chemistry Role of Mitochondria and Other ROS Sources in Hyperthyroidism-Linked Oxidative Stress
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) NAD+, Sirtuins, and Cardiovascular Disease
Current Pharmaceutical Design Therapeutic Potential of Erythropoietin in Retinal and Optic Nerve Diseases
CNS & Neurological Disorders - Drug Targets L-Arginine Availability as a Pathological Mechanism in Essential Hypertension, Chronic Renal and Heart Failure
Vascular Disease Prevention (Discontinued) Cardiovascular and Hematological Medicine in 2018 – Advances and Insights
Cardiovascular & Hematological Agents in Medicinal Chemistry Targeting Triglyceride Metabolism for Colorectal Cancer Prevention and Therapy
Current Drug Targets Recent Development of Copolymeric Nano-Drug Delivery System for Paclitaxel
Anti-Cancer Agents in Medicinal Chemistry SAR, QSAR and Docking of Anticancer Flavonoids and Variants: A Review
Current Topics in Medicinal Chemistry Editorial [Hot Topic Cardiovascular and Metabolic Diseases: from Mechanisms to Novel Therapeutical Implications Guest Editors: Attila Borbély and Pawel Petkow Dimitrow]
Current Pharmaceutical Biotechnology Anti-Apoptotic Effect of Human Telomerase Reverse Transcriptase on Endothelial Cells under Oxidative Stress, Independent of Telomere Elongation and Telomerase Activity
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) The Use of Carvedilol in Pediatric Heart Failure
Cardiovascular & Hematological Disorders-Drug Targets <i>Uncaria tomentosa</i> (Willd. ex Schult.): Focus on Nutraceutical Aspects
Current Bioactive Compounds Most Efficient Routes for the Synthesis of α,β-Diamino Acid-Derived Compounds
Current Pharmaceutical Design Evaluation of Oxidative Status with Exhaled Breath 8-isoprostane Levels in Patients with Hyperthyroidism
Endocrine, Metabolic & Immune Disorders - Drug Targets Molecular Mechanism of Anti-tumor Effect by Triptolide in Hematological Malignancies
Current Signal Transduction Therapy The Right Ventricle: Biologic Insights and Response to Disease: Updated
Current Cardiology Reviews Diabetic Heart and the Cardiovascular Surgeon
Cardiovascular & Hematological Disorders-Drug Targets Subject Index to Volume 4
Current Drug Targets The Central Vasopressinergic System: Examining the Opportunities for Psychiatric Drug Development
Current Pharmaceutical Design